Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q2 2016 · 10-Q
Revenue$219.69M$219.69M−3.5% vs Q2 2015 Net Income$12.86M$12.86M+71.8% vs Q2 2015 EPS Diluted$0.25$0.25+78.6% vs Q2 2015 Gross Profit$105,297,000−2.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$27,511,000−11.9% Free Cash Flowderived$1,627,000N/M Margins · derivedGross margin47.9%+0.4 pt vs Q2 2015
Operating margin8.7%+3.3 pt vs Q2 2015
Net margin5.9%+2.6 pt vs Q2 2015
ended Sep 26, 2015 · filed Nov 4, 2015 · 39 d after period end